AI assistant
GWR GROUP LIMITED — Director's Dealing 2017
Dec 21, 2017
65031_rns_2017-12-21_6c244821-e12f-41ef-824a-779609ae2372.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity GWR Group Limited ABN 54 102 622 051
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Tien SengLaw(surname underlined) |
|---|---|
| Date of last notice | 23 December 2016 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect (shares) and direct (options) |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. | For indirect interest, the registered holder of theshares is Wynnes Investment Holding Limited.Tan Sri Dato Tien Seng Law holds more than 20%of the voting power of the issued and paid up sharecapital of Wynnes Investment Holding Limited.Saw Geok Ngor, the wife of Law Tien Seng, holdsmore than 20% of the voting power of the issuedand paid up share capital of Wynnes InvestmentHolding Limited.Pursuant to Section 608(3) of the Corporation Act2001, Tan Sri Dato Tien Seng Law has a relevantinterest in securities held by Wynnes InvestmentHolding Limited. |
| Date of change | 22 December 2017 |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held prior to changes | No. of securities held prior to changes | No. of securities held prior to changes | 28,021,749 Ordinary shares (indirect)4,000,000 unlisted options: (direct)a) 800,000 unlisted options vested on grant,exercisable at $0.04 , expiring 23 December2020,b) 800,000 unlisted options, vesting 23December 2017, exercisable at $0.05,expiring 23 December 2020, | 28,021,749 Ordinary shares (indirect)4,000,000 unlisted options: (direct)a) 800,000 unlisted options vested on grant,exercisable at $0.04 , expiring 23 December2020,b) 800,000 unlisted options, vesting 23December 2017, exercisable at $0.05,expiring 23 December 2020, | 28,021,749 Ordinary shares (indirect)4,000,000 unlisted options: (direct)a) 800,000 unlisted options vested on grant,exercisable at $0.04 , expiring 23 December2020,b) 800,000 unlisted options, vesting 23December 2017, exercisable at $0.05,expiring 23 December 2020, | 28,021,749 Ordinary shares (indirect)4,000,000 unlisted options: (direct)a) 800,000 unlisted options vested on grant,exercisable at $0.04 , expiring 23 December2020,b) 800,000 unlisted options, vesting 23December 2017, exercisable at $0.05,expiring 23 December 2020, | |
|---|---|---|---|---|---|---|---|
| c) 2,400,000 unlisted options, vesting 23December 2018, exercisable at $0.06,expiring 23 December 2020. | |||||||
| Class | Ordinary shares | ||||||
| Number acquired | 577,543 Ordinary shares | ||||||
| Number disposed | Nil | ||||||
| Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation | $27,500 value of accrued salary | ||||||
| No. of securities held after change | 28,599,292 Ordinary shares (indirect)4,000,000 unlisted options: (direct)a) 800,000 unlisted options vested on grant,exercisable at $0.04 , expiring 23 December2020,b) 800,000 unlisted options, vesting 23December 2017, exercisable at $0.05,expiring 23 December 2020,c) 2,400,000 unlisted options, vesting 23December 2018, exercisable at $0.06,expiring 23 December 2020. | ||||||
| Nature of changeExample: on-market trade, off-market trade, exercise of options, issue | Issued in lieu of accrued Directors salary asapproved b shareholders at the AGM held on 24 | ||||||
| of securities under dividend reinvestment plan, participation in buy-bk | yNovember 2017 | ||||||
| ac | ac | ||||||
| Part 2 – Change of director’s inter | ests in contracts | ||||||
| Note: In the case of a company, interests which com | e within paragraph (ii) of the defi | nition of “notifiable interest of a dire | ctor” should | ||||
| be disclosed in this part.Detail of contract | |||||||
| Detail of contract | N/A | ||||||
| Nature of interest | N/A | ||||||
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| Name of registered holder | N/A |
|---|---|
| (if issued securities) | |
| Date of change | N/A |
| No. and class of securities to which | N/A |
| interest related prior to change | |
| Note: Details are only required for a contract in | |
| relation to which the interest has changed | |
| Interest acquired | N/A |
| Interest disposed | N/A |
| Value/Consideration | N/A |
| Note: If consideration is non-cash, provide details | |
| and an estimated valuation | |
| Interest after change | N/A |
Part 3 –[+] Closed period
| Were the interests in the securities or contracts detailed above | No |
|---|---|
| traded during a+closed period where prior written clearance | |
| was required? | |
| If so, was prior written clearance provided to allow the trade to | N/A |
| proceed during this period? | |
| If prior written clearance was provided, on what date was this | N/A |
| provided? |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3